
Sign up to save your podcasts
Or
This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting, the CONTACT03 Trial. We also cover subgroup analysis interpretation.
4.8
168168 ratings
This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting, the CONTACT03 Trial. We also cover subgroup analysis interpretation.
322 Listeners
496 Listeners
58 Listeners
272 Listeners
3,321 Listeners
1,081 Listeners
194 Listeners
43 Listeners
514 Listeners
321 Listeners
243 Listeners
105 Listeners
53 Listeners
363 Listeners
38 Listeners